Clinical analysis of Diyu Shengbai tablets combined with granulocyte colony stimulating factor in treatment of cancer related fatigue syndrome
- VernacularTitle:地榆升白片联合重组人粒细胞刺激因子治疗癌症相关性乏力的临床分析
- Author:
Chunyi LIU
;
Xinyan HU
;
Lixia XU
;
Yan KONG
;
Fengling LIU
- Publication Type:Journal Article
- Keywords:
Diyu Shengbai tablets;
granulocyte colony stimulating factor;
cancer related fatigue syndrome
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;(3):98-99
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analysis clinical effect of Diyu Shengbai tablets combined with granulocyte colony stimulating factor on cancer related fatigue syndrome.Methods II-VI primary cancer 60 patients from January 2011 to December 2013 were admitted to department of internal medicine, Fourth Hospital of Hebei Medical University,and randomly divided into two groups.Control goup(n=30)were treated with granulocyte colony stimulating factor(G-CSF).Experimental group(n=30)were treated with Diyu Shengbai tablets and G-CSF.Results After chemotherapy, ratio of patients in the experimental group appeared fatigue syndrome and changes in leukocyte was significantly lower than that of control group, the difference was statistically significant ( P <0.05 ) . Conclusion Diyu Shengbai tablets combined with G-CSF have better clinical efficacy for leukopenia caused by tumor chemotherapy, the symptom of fatigue also can improve significantly.
